Medical Technology Company, OxySure Systems, Reports Results for the 3rd Quarter - 14 Consecutive Quarters of Growth - Video News Alert on InvestmentPitch.com

Vancouver, British Columbia--(Newsfile Corp. - November 20, 2015) - Medical technology company, OxySure Systems (OTCQB: OXYS), announced results for the 3rd quarter, reporting 14 consecutive quarters of growth. OxySure focuses on the design, manufacture and distribution of specialty respiratory and medical solutions, having pioneered a ground-breaking technology to produce medically pure oxygen from inert powders, making the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen systems.

InvestmentPitch.com has produced a “video news alert” which provides a brief overview of the product and company. If this link is not enabled, please visit www.InvestmentPitch.com and enter “OxySure” in the search box.

If you cannot view the video above, please visit:
http://www.investmentpitch.com/vi deo/0_6iyjfwov/OxySure-Systems-OTCQB-OXYS-announced-results-for-the-3rd-quarter-reporting-14-consecutive-quarters-of-growth

For the three months ended September 30, 2015, revenues increased to $1,138,380 up 39% from the $818,456 reported in the third quarter of 2014, with gross profit also increasing by 12%, coming in at $558,254 versus $496,524) for the comparable period in 2014.

The company reported several highlights for the 9 month period, with working capital surplus up 253% to $1.5 million, total assets up 76% to $4.4 million, and shareholder equity up 103% to $2.2 million.

Commenting on the latest quarter, Julian T. Ross, Chairman & CEO, stated: "This has been a good building quarter for us. We were able to bring strong management to the opportunities and challenges along the way and we are pleased with the exemplary results."

In June, the company announced plans to add drones to carry kits designed for various types of emergencies or disasters, and was subsequently received exemption for commercial drone usage by the Federal Aviation Administration, a division of the United States Department of Transportation. The company anticipates that payloads could include automated external defibrillators and accessories for cardiac arrest patients, as well as kits for victims of fire, flood, earthquake, chemical spill and a number of other emergency categories.

The company has appointment PP Aviation Corporation as a non-exclusive distributor of its medical drones into military markets. PP Aviation is in the business of promoting and selling military products and oxygen equipment for military and aviation applications.

OxySure acted as an official Supplier of Medical Equipment for Health Services at the Special Olympics World Games held in Los Angeles from July 25th to August 2nd, where its OxySure Model 615 portable oxygen device was used in 18 potentially live saving situations.

The company placed 4th among the fastest growing technology companies in Northern Texas, receiving a Fast Tech Award.

However, all this growth came at a price, as the company reported a net loss of $0.04 per share for the quarter, an increase from the $0.02 net loss per share reported in the third quarter of 2014.

When asked about future plans, Ross stated: “Looking forward, we remain on track with the launch of at least one new solution in 2015. Also, we have started working with our medical advisors on laying the ground work for our direct to consumer campaign addressing "At Risk" markets such as Asthma and Immunology markets. We will be continuing our work on the Nasdaq uplisting process. Finally, our growth plan is working and our investments are paying dividends. We are especially excited about working towards one of our next key milestones, which is to reach the $10 million revenue run rate number and breakeven some time in 2016."

The company has received Board of Directors approval for a change of the Company's name to OxySure Therapeutics, Inc.

Independent equity research firm SeeThruEquity calls the company “an intriguing speculative medical device company entering what should be a significant growth year, with an innovative product targeting a large potential market.”

The shares are currently trading at $0.23, and with 33.5 million outstanding, the company is capitalized at $7.7 million.

For more information, please visit the company’s website www.oxysure.com.

In Canada, investor relations is handled by Bettina Filippone of Renmark Financial Communications, who can be reached at bfilippone@renmarkfinancial.com. In the US, please contact Jon Cunningham at Redchip Companies, who can be reached at jon@redchip.com.

About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases and research reports.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
bmorgan@investmentpitch.com